Mostrar el registro sencillo del ítem

Procédé de fabrication d'une forme pharmaceutique à libération contrôlée contenant au moins un principe actif

hal.structure.identifierEllipse Pharmaceutical
dc.contributor.authorLACAZE SAINT-JEAN, Catherine
hal.structure.identifierEllipse Pharmaceutical
dc.contributor.authorGRISLAIN, Luc
hal.structure.identifierEllipse Pharmaceutical
dc.contributor.authorBERGUA, Thomas
hal.structure.identifierEllipse Pharmaceutical
dc.contributor.authorBOUTIGNON, François
hal.structure.identifierInstitut de Chimie de la Matière Condensée de Bordeaux [ICMCB]
dc.contributor.authorDEMAZEAU, Gérard
hal.structure.identifierInstitut de Chimie de la Matière Condensée de Bordeaux [ICMCB]
dc.contributor.authorLARGETEAU, Alain
dc.date.issued2006-01-06
dc.description.abstractEnA manufg. process for an administrable or implantable controlled-release dosage form contg. at least an active ingredient comprises mixing the active ingredients with a vector comprising one or more excipients and subjecting the mixt. to a treatment by high isostatic pressure ranging from 100-700 MPa for a length of time ranging between 1 and 60 min, to form the pharmaceutical form. Pharmaceutical forms obtained by this process are implanted or administered by oral, nasal, parenteral, vaginal, rectal or ophthalmic route. A tablet contg. ibuprofen 60, lactose 35, talc 4, colloidal silica 0.5, and magnesium stearate 0.5% was prepd. according to the above process.
dc.language.isofr
dc.subject.enDrug delivery system
dc.subject.enPressure
dc.subject.enVinyl compounds
dc.subject.enAcrylic polymers
dc.subject.enInsulin
dc.subject.enIbuprofen
dc.subject.enResomer rg 502h
dc.subject.enBiological studies
dc.titleProcédé de fabrication d'une forme pharmaceutique à libération contrôlée contenant au moins un principe actif
dc.typeBrevet
dc.subject.halChimie/Matériaux
bordeaux.page22
bordeaux.countryFR
bordeaux.brevet.numberFR 2872429
hal.identifierhal-00018632
hal.version1
hal.origin.linkhttps://hal.archives-ouvertes.fr//hal-00018632v1
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.title=Proc%C3%A9d%C3%A9%20de%20fabrication%20d'une%20forme%20pharmaceutique%20%C3%A0%20lib%C3%A9ration%20contr%C3%B4l%C3%A9e%20contenant%20au%20moins%20un%20principe%20actif&rft.atitle=Proc%C3%A9d%C3%A9%20de%20fabrication%20d'une%20forme%20pharmaceutique%20%C3%A0%20lib%C3%A9ration%20contr%C3%B4l%C3%A9e%20contenant%20au%20moins%20un%20principe%20actif&rft.date=2006-01-06&rft.spage=22&rft.epage=22&rft.au=LACAZE%20SAINT-JEAN,%20Catherine&GRISLAIN,%20Luc&BERGUA,%20Thomas&BOUTIGNON,%20Fran%C3%A7ois&DEMAZEAU,%20G%C3%A9rard&rft.genre=unknown


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem